SEPARATION & RELEASE AGREEMENTSeparation & Release Agreement • March 31st, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Ohio
This Separation and Release Agreement (“Agreement”), effective March 30, 2023 (the “Effective Date”), is hereby agreed to by and between Navidea Biopharmaceuticals, Inc. (the “Company”) and Michael Rosol (“Employee”) (either party individually, a “Party” or collectively referred to as the “Parties”) as of the Separation Date (defined below).
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • March 31st, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Colorado
THIS CONSULTING SERVICES AGREEMENT, dated as of March 30, 2023, is by and between Navidea 4995 Bradenton Avenue Suite 240 Dublin, OH 43017 (the “Company”) , and G2G Ventures with an address at: 1746 Cole Blvd Building 21, Suite 300 Lakewood, Co 80401-3208 (the “Consultant”).
